Get notified when SILO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSilo Pharma completes 1-for-15 reverse stock split to boost share price
Filed June 3, 2026 · Period ending June 1, 2026 · ~1 min read
Key Changes
-
high
Reverse stock split became effective June 2, 2026 at 4:01 p.m. ET, with every 15 shares combined into 1 share. Split-adjusted trading began June 3 on Nasdaq under ticker SILO with new CUSIP 82711P 300.
Item 5.03: Reverse Stock Split verify on EDGAR → -
medium
Authorized shares reduced proportionately to 6,666,667 shares while par value remains $0.0001 per share, maintaining the same ratio of authorized to outstanding shares as before the split.
Item 5.03: Authorized Shares verify on EDGAR → -
medium
All outstanding stock options, warrants, and equity plan reserves adjusted proportionately—exercise prices increased 15x while share counts decreased by factor of 15, preserving economic value for holders.
Item 5.03: Equity Awards verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade SILO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify